Evotec SE (EVO)
NASDAQ: EVO · IEX Real-Time Price · USD
5.27
-0.10 (-1.86%)
At close: May 3, 2024, 4:00 PM
5.28
+0.01 (0.19%)
After-hours: May 3, 2024, 5:09 PM EDT
Evotec SE Employees
Evotec SE had 4,952 employees on December 31, 2022. The number of employees increased by 754 or 17.96% compared to the previous year.
Employees
4,952
Change (1Y)
754
Growth (1Y)
17.96%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
1.87B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 4,952 | 754 | 17.96% |
Dec 31, 2021 | 4,198 | 3,995 | 1,967.98% |
Dec 31, 2009 | 203 | 0 | - |
Dec 31, 2008 | 203 | 0 | - |
Dec 31, 2007 | 203 | -396 | -66.11% |
Dec 31, 2006 | 599 | -14 | -2.28% |
Dec 31, 2005 | 613 | -26 | -4.07% |
Dec 31, 2004 | 639 | -7 | -1.08% |
Dec 31, 2003 | 646 | 27 | 4.36% |
Dec 31, 2002 | 619 | 34 | 5.81% |
Dec 31, 2001 | 585 | 277 | 89.94% |
Dec 31, 2000 | 308 | 110 | 55.56% |
Dec 31, 1999 | 198 | 72 | 57.14% |
Dec 31, 1998 | 126 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Galapagos NV | 1,123 |
Alphatec Holdings | 839 |
Beam Therapeutics | 507 |
Harmony Biosciences Holdings | 246 |
Syndax Pharmaceuticals | 184 |
Avadel Pharmaceuticals | 154 |
Structure Therapeutics | 93 |
Edgewise Therapeutics | 88 |
EVO News
- 5 days ago - Bayer and Evotec Collaborate to Advance Precision Cardiology - Accesswire
- 11 days ago - Evotec shares lose a third of their value on cloudy outlook - Market Watch
- 11 days ago - Evotec Presents Fiscal Year 2023 Results and Announces Priority Reset to Focus on Profitable Growth - Accesswire
- 12 days ago - Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer - Accesswire
- 17 days ago - Evotec and Variant Bio Enter Strategic Partnership to Discover and Develop Fibrosis Treatments - Accesswire
- 17 days ago - EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS - PRNewsWire
- 18 days ago - Evotec SE to Announce Results for Fiscal Year 2023 on 24 April 2024 - Accesswire
- 18 days ago - Evotec welcomes Aurélie Dalbiez as Chief People Officer - Accesswire